Free Trial

Bio-Rad Laboratories (BIO.B) Competitors

$300.39
+16.94 (+5.98%)
(As of 10:25 AM ET)

BIO.B vs. AVTR, ST, OLK, TRNS, OPXS, RPID, AXDX, THMO, MTD, and ILMN

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Avantor (AVTR), Sensata Technologies (ST), Olink Holding AB (publ) (OLK), Transcat (TRNS), Optex Systems (OPXS), Rapid Micro Biosystems (RPID), Accelerate Diagnostics (AXDX), ThermoGenesis (THMO), Mettler-Toledo International (MTD), and Illumina (ILMN).

Bio-Rad Laboratories vs.

Bio-Rad Laboratories (NYSE:BIO.B) and Avantor (NYSE:AVTR) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.

Avantor received 46 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. Likewise, 63.81% of users gave Avantor an outperform vote while only 57.60% of users gave Bio-Rad Laboratories an outperform vote.

CompanyUnderperformOutperform
Bio-Rad LaboratoriesOutperform Votes
125
57.60%
Underperform Votes
92
42.40%
AvantorOutperform Votes
171
63.81%
Underperform Votes
97
36.19%

0.0% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 28.4% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 1.5% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Avantor had 11 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 13 mentions for Avantor and 2 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 0.98 beat Avantor's score of 0.92 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avantor has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.67B3.03-$637.32M-$10.36-27.36
Avantor$6.97B2.02$321.10M$0.3953.18

Avantor has a consensus target price of $25.93, indicating a potential upside of 25.02%. Given Avantor's higher probable upside, analysts plainly believe Avantor is more favorable than Bio-Rad Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Avantor
0 Sell rating(s)
5 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.69

Avantor has a net margin of 3.79% compared to Bio-Rad Laboratories' net margin of -12.37%. Avantor's return on equity of 13.01% beat Bio-Rad Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories-12.37% 3.59% 2.55%
Avantor 3.79%13.01%5.22%

Bio-Rad Laboratories has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Avantor has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.

Summary

Avantor beats Bio-Rad Laboratories on 14 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO.B vs. The Competition

MetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$8.08B$5.22B$5.23B$18.32B
Dividend YieldN/A0.42%2.82%3.46%
P/E Ratio-27.3629.59155.6525.27
Price / Sales3.034.652,068.4315.39
Price / Cash23.4243.9036.4120.69
Price / Book0.923.274.905.07
Net Income-$637.32M-$396,363.64$110.92M$974.25M
7 Day PerformanceN/A1.08%0.96%1.55%
1 Month PerformanceN/A0.53%7.41%5.02%
1 Year Performance-26.86%-35.94%4.37%7.67%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
4.8955 of 5 stars
4.90 / 5 stars
$20.82
+0.1%
$25.93
+24.5%
-1.3%$14.14B$6.97B53.3814,500Upcoming Earnings
ST
Sensata Technologies
4.3758 of 5 stars
4.38 / 5 stars
$40.91
+0.5%
$43.78
+7.0%
-12.0%$6.16B$4.05B-371.8819,400News Coverage
Positive News
OLK
Olink Holding AB (publ)
0.3203 of 5 stars
0.32 / 5 stars
$26.08
flat
$26.00
-0.3%
+35.8%$3.24B$170.89M-96.59420
TRNS
Transcat
1.7952 of 5 stars
1.80 / 5 stars
$130.80
+0.9%
$142.67
+9.1%
+57.0%$1.19B$259.48M82.261,104
OPXS
Optex Systems
0 of 5 stars
0.00 / 5 stars
$8.18
+4.2%
N/A+130.7%$56.06M$30.74M15.7380News Coverage
High Trading Volume
RPID
Rapid Micro Biosystems
0.7473 of 5 stars
0.75 / 5 stars
$0.65
-4.4%
N/A-35.9%$27.95M$22.52M-0.54200Gap Up
AXDX
Accelerate Diagnostics
2.3016 of 5 stars
2.30 / 5 stars
$1.15
flat
$1.00
-13.0%
-83.2%$25.36M$12.06M-0.28220Analyst Forecast
Gap Up
THMO
ThermoGenesis
0.9882 of 5 stars
0.99 / 5 stars
$0.18
+20.0%
$5.00
+2,677.8%
-91.3%$1.43M$9.61M-0.0440Gap Down
MTD
Mettler-Toledo International
4.2618 of 5 stars
4.26 / 5 stars
$1,358.54
0.0%
$1,301.25
-4.2%
+1.6%$29.02B$3.79B38.1017,300Positive News
ILMN
Illumina
4.8754 of 5 stars
4.88 / 5 stars
$116.56
+0.4%
$158.57
+36.0%
-35.8%$18.57B$4.50B-14.309,300Positive News

Related Companies and Tools

This page (NYSE:BIO.B) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners